Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association

Khadijah Breathett et al. Circulation. .

Abstract

Guideline-directed medical therapies and guideline-directed nonpharmacological therapies improve quality of life and survival in patients with heart failure (HF), but eligible patients, particularly women and individuals from underrepresented racial and ethnic groups, are often not treated with these therapies. Implementation science uses evidence-based theories and frameworks to identify strategies that facilitate uptake of evidence to improve health. In this scientific statement, we provide an overview of implementation trials in HF, assess their use of conceptual frameworks and health equity principles, and provide pragmatic guidance for equity in HF. Overall, behavioral nudges, multidisciplinary care, and digital health strategies increased uptake of therapies in HF effectively but did not include equity goals. Few HF studies focused on achieving equity in HF by engaging stakeholders, quantifying barriers and facilitators to HF therapies, developing strategies for equity informed by theory or frameworks, evaluating implementation measures for equity, and titrating strategies for equity. Among these HF equity studies, feasibility was established in using various educational strategies to promote organizational change and equitable care. A couple include ongoing randomized controlled pragmatic trials for HF equity. There is great need for additional HF implementation trials designed to promote delivery of equitable guideline-directed therapy.

Keywords: AHA Scientific Statements; health disparities; health equity; heart failure; heart transplant; implementation science; pragmatic clinical trials as topic; race factors; women’s health.

PubMed Disclaimer

Conflict of interest statement

The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.

Figures

Figure.
Figure.. Close the HF equity and implementation gaps by lowering the drawbridge.
The open drawbridge represents the heart failure (HF) equity and implementation gaps between underrepresented racial and ethnic groups receiving evidence-based HF treatments. Drawbridges work by initiation of cogwheels on each side of the bridge that allow both sides of the bridge to open and close. An open drawbridge contributes to increasing HF morbidity and mortality, particularly for underrepresented racial and ethnic groups. The HF equity and implementation gaps may be closed by simultaneously starting the gears to lower the drawbridge on both sides of the bridge. This includes the following steps: (1) identify HF equity and implementation gaps; (2) engage diverse stakeholders; (3) select equity framework and implementation framework that consider equity; (4) identify barriers and facilitators to equitable treatment for HF; (5) use implementation strategies with target, temporality, and dose; and (6) assess equity measures for success. SDOH indicates social determinants of health.

References

    1. Mwansa H, Lewsey S, Mazimba S, Breathett K. Racial/ethnic and gender disparities in heart failure with reduced ejection fraction. Curr Heart Fail Rep. 2021;18:41–51. doi: 10.1007/s11897-021-00502-5 - DOI - PMC - PubMed
    1. Lewsey SC, Breathett K. Equity in heart transplant allocation: intended progress up the hill or an impossibility? J Am Heart Assoc. 2021;10:e022817. doi: 10.1161/JAHA.121.022817 - DOI - PMC - PubMed
    1. Nayak A, Hicks AJ, Morris AA. Understanding the complexity of heart failure risk and treatment in Black patients. Circ Heart Fail. 2020;13:e007264. doi: 10.1161/CIRCHEARTFAILURE.120.007264 - DOI - PMC - PubMed
    1. Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Pedro Ferreira J, Zannad F, Packer M, Fonarow GC, McMurray JJV, Solomon SD. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Lancet. 2020;396:121–128. doi: 10.1016/S0140-6736(20)30748-0 - DOI - PubMed
    1. Greene SJ, Khan MS. Quadruple medical therapy for heart failure: medications working together to provide the best care. J Am Coll Cardiol. 2021;77:1408–1411. doi: 10.1016/j.jacc.2021.02.006 - DOI - PubMed